2021-06-18-世界卫生组织-44th_ECDD_List_of_Substances_1页_77kb

ECDD 44th Meeting Summary: Substance Review for International Control

Date: 11-15 October 2021

The 44th Expert Committee on Drug Dependence (ECDD) meeting reviewed various substances to determine their eligibility for potential scheduling under the 1961 or 1971 Conventions. The substances were identified based on criteria including no prior WHO review, no recognized therapeutic use, and risks to public health.

Critical reviews were conducted for substances newly introduced to clinical concern, typically those not under international control. This process evaluates whether information justifies scheduling or changes to existing schedules.

• Synthetic cannabinoid receptor agonist: 4F-MDMB-BICA
• Novel synthetic opioids: Brorphine, Metonitazene
• Cathinones/stimulants: Eutylone, Benzylone

Pre-reviews involved preliminary analysis to assess if current information supports a formal critical review, helping to prioritize or prepare for future evaluations. These substances are not yet under international control.

• Herbal drugs: Kratom, mitragynine, 7-hydroxymitragynine
• Medicines: Phenibut

The meeting aimed to address substances posing serious public health risks, with decisions based on evidence presented during the reviews.